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Acetic acid bacteria (AAB) have a long history of application in several fermentation processes. Their exploitation gradually emerged in 
biotechnological utilizations, particularly in the 
biosynthesis of beneficial chemicals and processes for 
manufacturing of several fermented food products. 
Taxonomic studies, from the traditional to polyphasic 
approaches, have gradually allowed an appropriate 
classification of several ABB into distinct genera and 
species. For instance, the bacterial nanocellulose (BNC) 
producers, notably Komagataeibacter xylinus, exemplifies 
them.1 These bacteria secrete cellulose as nano/microfibrils 
from a row of synthetic sites, along the longitudinal axis 
of the cell, which then merge to form larger cellulose 
ribbons. Under static culture conditions, these ribbons 
and associated cells, form a 3D-nanofibrilar floating 
pellicle that allows the non-motile, strictly aerobic bacteria 
to grow in the top oxygen-rich interface of the growth 
medium. Under agitated and/or aerated conditions, 
BNC is obtained in the form of fleeces with variable size. 
Compared to other sources, BNC is characterized by a 
native nanofibrillar structure, higher purity (as is deprived 
of non-cellulosic material) and a higher tensile strength. 
Also, it shows high moldability in situ, high water holding 
capacity and high crystallinity. The unique properties of 
BNC and, because of these, its wide range of potential 
applications, have been widely reported in the literature.2-4
Commercial exploitation of BNC has its roots in the 
Philippines, from as early as 1819, from an accidental 
discovery in Laguna, in which pineapple peels exploited 
in bleaching the pina cloth, was used as a culture medium 
for the growth and cellulose production from AAB. After 
several fermentation trials under static culture, Nata de 
Coco (BNC) cottage industry has grown to become a 
successful traditional fermented food business in several 
countries of the Pacific region.5-11 
It has been demonstrated that BNC may outperform 
the currently used celluloses in the food industry as 
a promising novel hydrocolloid additive. Potential 
utilizations of BNC in food technology are pourable and 
spoonable dressings, sauces, and gravies; frostings and 
icings; sour cream and cultured dairy products; whipped 
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Article Info  Summary
Acetic acid bacteria (AAB) have been used in 
various fermentation processes. Of several ABB, the 
bacterial nanocellulose (BNC) producers, notably 
Komagataeibacter xylinus, appears as an interesting 
species, in large part because of their ability in the 
secretion of cellulose as nano/microfibrils. In fact, 
BNC is characterized by a native nanofibrillar 
structure, which may outperform the currently 
used celluloses in the food industry as a promising 
novel hydrocolloid additive. During the last couple 
of years, a number of companies worldwide have 
introduced some BNC-based products to the market. 
The main aim of this editorial is to underline the 
BNC potentials. 
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toppings and aerated desserts, and frozen dairy products. 
Its use is specifically recommended in some special 
issues are required, including low use levels, lack of flavor 
interactions, foam stabilization, and stability over wide 
pH range, temperature, and freeze-thaw conditions. The 
utilization of BNC along with other agents (e.g., sucrose and 
carboxymethyl-cellulose) can ameliorate the dispersion of 
the product. Further, it is a low-calorie additive, thickener, 
stabilizer, texture modifier, and hence can be exploited in 
pasty condiments and in ice cream.12-15 Strong competition 
with colloidal MCC and other commercially available and 
well-established hydrocolloids in the food industry, makes 
the viability of such developments further uncertain.16 
Furthermore, the exploitation of nata de coco products 
seems not to have been fully done, and there seems to 
be room for its usage, as a novel food, in sophisticated 
molecular gastronomy products. 
Indeed, the technical and dietetic properties of BNC are 
indisputable. However, and despite some historical efforts, 
BNC still has not been made available commercially 
as a bulk product (especially in Western countries); 
nor and consequently has it been translated to actual 
products as a novel food additive or ingredient. In the 
1990s, several Japanese companies such as Ajinomoto, 
Shimazu Construction, Nikki, Mitsubishi Paper, Nikkiso 
and Nakamori Vinegar and national governmental 
organizations such as Japan Key Technology Centre, 
a joint organization under Ministry of International 
Trade and Industry (MITI) and the Ministry of Post 
and Telecommunications have collaborated to set up 
interdisciplinary research programs on the commercial 
production of microbial cellulose.17 Nevertheless, 
because of the lack of efficient fermentation systems, 
the commercial production of BC was never achieved. 
Another example of the tentative large-scale production 
and commercialization of BC, is seen by the joint effort of 
two American companies, namely the Cetus Corporation 
(Emeryville, California) and Weyerhaeuser Company 
(Tacoma, Washington), by using a deep tank fermentation 
technique.18,19 With this technology, a commercial product, 
called CellulonTM (a mixture of BC and sucrose), was aimed 
at different applications, including human food. By mid-
nineties, NutraSweet Kelco Company (USA) purchased 
the microbial cellulose business from Weyerhaeuser and 
launched the BC product as PrimaCelTM (BC combined 
with sucrose and carboxymethyl cellulose), also aimed 
at food applications.20,21 These products, however, never 
reached to full commercial scale, presumably due to the 
high capital and production costs involvement. 
As with many food businesses, Nata de Coco trade is 
characterized by high production volumes and low profit 
margins. On the other end of the spectra, associated with 
high-value-added niche markets, medical applications 
of BNC mostly include its use as wound dressings, 
with few examples of commercial products having 
been on the market, resulting from the exploitation of 
biotechnological fermentation BNC process. The first 
efforts to commercialize BC on a large scale, initiated 
by Johnson & Johnson in the early 80s. This company 
made extensive research on the medical application of 
BC as a wound care dressing22,23 and developed a highly 
purified membrane for the replacement of the dura mater 
(by Depuis Synthes: https://www.depuysynthes.com/). 
However, such commercial products do not involve 
large-scale fermentation systems. By 1996, the company’s 
patents were subsequently licensed exclusive worldwide 
rights to Xylos Corporation (Langhorne, USA), a company 
responsible for manufacturing of the XCell® family of BC-
based wound care products. Xylos commercialized their 
products in 2000-2003,24 but the business was also sold to 
Lohmann and Rauscher, in 2012. In the same line, BioFill 
Produtos Bioetecnológicos (Curitiba, PR Brazil) produced 
a range of products based on BC, including Biofill® and 
Bioprocess®, also for using in the therapy of burns, skin 
wounds and ulcers as temporary artificial skin; Gengiflex® 
was aimed at the treatment of periodontal disease. This 
company is no longer active. Examples of other spinoff 
companies active in the biomedical field include JenaCell, 
Polymet Jena and FZMB, all in Germany. In biomedicine, 
BNC can precisely be highly competitive in the use for 
tissues replacement and reconstruction. Apart from tensile 
strength and the simplicity of use, if offers properties 
like high water holding capacity, biocompatibility and 
internal structure mimicking the extracellular matrix, 
which make this biopolymer quite attractive as a 
potential tissue-engineered implant; further, due to the 
hydrophilic nature of BNC, water is abundantly kept 
within the nanofibiril network and the material behaves 
as a hydrogel. Biocompatibility of BNC has already been 
investigated plentifully, with very good results each time. 
The first described medical application of BNC concerned 
the healing of skin wounds. Owing to its hydrophilic 
properties, BNC was discovered to be an excellent 
hydrogel for dressings production. However, only in 2006, 
Polish scientists from Lodz University of Technology 
published the first results of BNC membranes application 
in clinical treatment of second and third degree burns. 
The investigations showed that BNC membranes could 
significantly facilitate the process of scar formation by the 
removal of necrotic debris and improved the development 
of granulation tissue. As a result, it could accelerate the 
entire process of re-epithelialization, in comparison to 
traditional treatment methods. At the same time BNC 
dressings offered a substantial decrease in daily wound 
care needs and patients pain relief in comparison with 
control procedures. 
This technology was recently bought by a Polish 
company – BOWIL Biotech Ltd., that has already started 
the production of BNC wound dressings and BNC-based 
cosmetic products (facial and eye masks) under the 
general name of CELMAT®. The extraordinary properties 
of BNC hydrogel applied for wounds healing and for 
internal tissues restoration, gave rise to the new area of 
BNC’s medical use, acting naturally as an entry gate into 
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the domain of drug delivery systems.
Much effort has been devoted to designing an 
economical process for the production of BNC, through 
optimizing both the upstream and downstream processes. 
These efforts include the evaluation of several culture 
media compositions, fermentation systems, genetic 
engineering and post-production modification processes. 
However, still the scientific literature propagates the idea 
that the technological production of BNC is extremely 
expensive. Indeed, and as observed above, from the rise 
and fall of several BC production companies, insofar, 
biotechnological processes are highly capital-intensive as 
compared with traditional BNC fermentation methods. 
Coupled to the usually low BNC yields, the high capital 
investment and high operating costs associated, present a 
strong economic constraint to the commercialization of 
BNC at a “low” cost (as compared to nata de coco). Still, 
and due to the unique properties of BNC and the almost-
reachable market potential, large efforts take place to 
enhance BNC from a food to a new generation of nature-
based sophisticated materials. During the last couple 
of years, several young companies worldwide started to 
bring such BNC-based products to the market. The key 
question remains to be answered: will the modern BNC 
industry remain restricted to high-value niche markets? 
The next few years should witness major progresses in the 
area and provide an answer to this question.
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